TABLE 1.
Correlation between PUF60 and clinical pathology characteristics in bladder cancer of tissue microarray data.
| Variable | NO. | PUF60 |
X2 | P Valve | |
| Low expression | High expression | ||||
| Age | |||||
| <60 | 12 | 3 (25.0%) | 9 (75.0%) | 2.363 | 0.124 |
| >60 | 42 | 21 (50.0%) | 21 (50.0%) | ||
| Gender | |||||
| Female | 8 | 2 (25.0%) | 6 (75.0%) | 1.438 | 0.23 |
| Male | 46 | 22 (47.8%) | 24 (52.2%) | ||
| T stage | |||||
| Tis | 5 | 3 (60.0%) | 2 (40.0%) | 0.997 | 0.91 |
| 1 | 10 | 5 (50.0%) | 5 (50.0%) | ||
| 2 | 14 | 6 (42.9%) | 8 (57.1%) | ||
| 3 | 21 | 8 (38.1%) | 13 (61.9%) | ||
| 4 | 2 | 1 (50.0%) | 1 (50.0%) | ||
| N stage | |||||
| 0 | 33 | 15 (45.5%) | 18 (54.5%) | 0.042 | 0.837 |
| 1 | 6 | 3 (50.0%) | 3 (50.0%) | ||
| AJCC stage | |||||
| Ois | 3 | 2 (66.7%) | 1 (33.3%) | 7.061 | 0.133 |
| I | 6 | 3 (50.0%) | 3 (50.0%) | ||
| II | 12 | 2 (16.7%) | 10 (83.3%) | ||
| III | 12 | 8 (66.7%) | 4 (33.3%) | ||
| IV | 7 | 4 (57.1%) | 3 (42.9%) | ||
| Pathological grade | |||||
| II | 16 | 5 (31.3%) | 11 (68.8%) | 1.603 | 0.205 |
| II–III/III | 38 | 19 (50.0%) | 19 (50.0%) | ||